Agenda and minutes

Apologies for absence were received from Debbie Barnes (Executive Director Children's Services), Dr Vindi Bhandal (South West Lincolnshire CCG), Dr Sunil Hindocha (Lincolnshire West CCG), Dr Simon Lowe (Lincolnshire East CCG) and Councillor C N Worth (Executive Councillor for Libraries, Heritage, Culture).

It was noted that Stuart Carlton (Assistant Director – Lead Early Help), Allan Kitt (South West Lincolnshire CCG), Sarah Newton (Lincolnshire West CCG) had replaced Debbie Barnes (Executive Director Children's Services), Dr Vindi Bhandal (South West Lincolnshire CCG), Dr Sunil Hindocha (Lincolnshire West CCG) respectively, for this meeting only.

There were no declarations of members' interests declared at this stage of the meeting.

(To receive a presentation from Dr Tony Hill (Chairman of the Lincolnshire Health and Care Programme Board) (LHAC) and David O'Connor (Programme Director of the Health and Care Programme Board) (LHAC), which will provide the Board with an update on progress made with Lincolnshire Health and Care)

Consideration was given to a report from the Chairman of the Lincolnshire Health and Care Programme Board, which provided the Board with an update, which sought to address:

·         The process for developing the proposal for change and business case assurance;

·         Formal decision making on the proposal and the business case;

·         Formal consultation; and

·         Responding to the formal consultation and agreeing the final proposal for change and the business case.

Appendix A to the report provided a revised summary timeline, which had been considered by the LHAC Programme Board earlier in the day.

The Chairman of the Lincolnshire Health and Care Programme Board reported that over the last couple of months the detail of the blue print had been developed, this had been achieved through three meetings of the four Care Design Groups set up for Phase 1, which had resulted in a Care Summit on 8 May 2014.  The Board were advised that 260 people had attended the aforementioned Care Summit.

The Care Design work had been informed by external facilitation and technical input from Pricewaterhouse Coopers LLP and input from informal engagement with a wide range of stakeholders across the county and including Healthwatch.

It was highlighted that work was underway to develop the scope and deployment of Neighbourhood Teams.  Also, in addition, work had been done to establish the current state of several enablers which were Workforce, Transport, Information Management & Technology, Estates and Contracting.

The Programme Director for Lincolnshire Health and Care advised that over the next six weeks a modelling process would take place, which would include impact assessments and options appraisals.  Following this process, a proposal for change and a business case would be produced.  This would then be revisited following the formal consultation process. 

Reassurance was given that assurance of the proposal would involve both internal and external mechanisms.  The internal assurance for the clinical options was being obtained through the engagement of senior clinicians in Care Design.   The internal assurance for the financial issues would be going through LCC and the NHS Finance Officers Group.

It was highlighted that as LHAC was identifying significant changes to services, it would therefore be subject to mandatory external assurance from the NHS Area Team.  It was highlighted further that there was no mandatory external assurance for social care changes.

The Board were advised that LHAC was the first programme to go through the new NHS assurance process in the East Midlands.  The assurance requirements focussed on the four tests set out in the 2014/15 Mandate from the Government to NHS England, which were:

·         Strong public and patient engagement;

·         Consistency with current and prospective need for patient choice;

·         Clear clinical evidence base; and

·         Support for proposals from clinical commissioners.

It was noted that in addition to this, the proposals for change had to be supported by a business case which would take into account not only the four tests, but also clinical sustainability within available resources, which would be underpinned by robust economic and financial evidence.

It  ...  view the full minutes text for item 62.